[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342070-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342070-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","pacsin1-promotes-immunosuppression-in-gastric-cancer-by-degrading-mhc-i","PACSIN1 promotes immunosuppression in gastric cancer by degrading MHC-I","","Gastric cancer (GC) is a prevalent gastrointestinal malignancy, and PACSIN1 is identified as an oncogenic factor across cancers. The study evaluates PACSIN1 as a therapeutic target in GC by measuring gene expression with RT-qPCR, immunofluorescence, and immunohistochemistry, and assessing PACSIN1–MHC-I colocalization via FISH. Flow cytometry and in vivo experiments examine cytokine release and cell function, with H&E histology supporting pathological findings. PACSIN1 overexpression correlates with immunologically cold tumors and poor prognosis, while PACSIN1 deficiency suppresses autophagy and increases antigen presentation by disrupting lysosomal fusion and selective autophagy of MHC-I, enhancing CD8+ T-cell infiltration and reducing tumor growth and liver metastasis. PACSIN1 knockout also improves chemosensitivity to immune checkpoint blockade.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/pacsin1-promotes-immunosuppression-in-gastric-cancer-by-degrading-mhc-i/342070/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/pacsin1-promotes-immunosuppression-in-gastric-cancer-by-degrading-mhc-i/342070.png","ImageObject",300,407,{"name":42,"@type":43},"Eden","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the study’s main goal regarding PACSIN1 in gastric cancer?","Question",{"text":63,"@type":64},"To investigate whether PACSIN1 can serve as a target for GC treatment by clarifying its role in tumor biology and antitumor immunity.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does PACSIN1 deficiency affect autophagy and antigen presentation in GC cells?",{"text":68,"@type":64},"PACSIN1 deficiency inhibits autophagy but increases antigen presentation by disrupting lysosomal fusion and selective autophagy of MHC-I.",{"name":70,"@type":61,"acceptedAnswer":71},"What are the in vivo effects of PACSIN1 knockout on tumor progression and immune infiltration?",{"text":72,"@type":64},"PACSIN1 knockout suppresses tumor growth and liver metastasis in vivo while increasing CD8+ T-cell infiltration.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342070,1790210820,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":123,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Original Article  \nPACSIN1 promotes immunosuppression in gastric cancer by degrading MHC-I  \nZhu Liu1,3,4,5,†, Xin Li3,6,†, Ali Muhammad2,4,5,†, Qiannan Sun3,4,5, Qi Zhang3,4,5, Yang Wang2,4,5, Yong Wang3,4,5, Jun Ren2,3,4,5, *, and Daorong Wang 1,2,3,4,5, *  \n1The Yangzhou School of Clinical Medicine of Nanjing Medical University, Yangzhou 225001, China, 2Clinical Medical College, Yangzhou University, Yangzhou 225001, China, 3 Northern Jiangsu People’s Hospital, Yangzhou 225001, China, 4General Surgery Institute of Yangzhou, Yangzhou University, Yangzhou 225001, China, 5Yangzhou Key Laboratory of Basic and Clinical Transformation of Digestive and Metabolic Diseases, Yangzhou 225001, China, and 6 Department of Pharmacy, Clinical Medical College, Yangzhou University, Northern Jiangsu People’s Hospital, Yangzhou 225001, China  \n†These authors contributed equally to this work.  \n*Correspondence address. Tel: +86-18051062590; [E-mail:](E-mail: wdaorong666@sina.com)[ wdaorong666@sina.com](E-mail: wdaorong666@sina.com) (D.W. ) / E-mail: [freezingfall@163.com](freezingfall@163.com) (J. R. ) Received 19 January 2024 Accepted 7 March 2024  \nAbstract  \nGastric cancer (GC) is a common gastrointestinal system malignancy. PACSIN1 functions as an oncogene in various cancers. This study aims to investigate the potential of PACSIN1 as a target in GC treatment. Gene expression is determined by RT-qPCR, immunofluorescence staining, and immunohistochemistry assay. FISH is performed to determine the colocalization of PACSIN1 and the major histocompatibility complex (MHC-I) . Cytokine release and cell functions are analyzed by flow cytometry. In vivo assays are also conducted. Histological analysis is performed using H&E staining. The results show that PACSIN1 is overexpressed in GC patients, especially in those with immunologically-cold tumors. A high level of PACSIN1 is associated with poor prognosis. PACSIN1 deficiency inhibits autophagy but increases antigen presentation in GC cells. Moreover, PACSIN1 deficiency inhibits the lysosomal fusion and selective autophagy of MHC-I, increases CD8 + T-cell infiltration, and suppresses tumor growth and liver metastasis in vivo. Additionally, PACSIN1 knockout enhances the chemosensitivity of cells to immune checkpoint blockade. In summary, PACSIN1 mediates lysosomal fusion and selective autophagy of MHC-I and suppresses antigen presentation and CD8 + T-cell infiltration, thus inhibiting antitumor immunity in GC.  \nKey words gastric cancer, PACSIN1, autophagy, MHC-I, CD8+ T cell  \nIntroduction  \nGastric cancer (GC) ranks the fifth most common malignant cancer [1,2] . Compared to that in 2014, the mortality of GC is increased by 1.4%[3] . In China, the incidence rate of GC ranks second among all cancers [4] . Although great advances have been made in GC therapies in recent decades, the clinical outcomes are still unsatisfactory [5] . The 5-year mortality rate of GC is still over 30% [6] . This is because most patients are diagnosed at an advanced stage with acquired chemoresistance [7–10] . Therefore, identifying the molecular mechanisms underlying the pathogenesis of GC may provide novel strategies for the treatment of GC.  \nImmune checkpoint blockade (ICB) strategies, especially anti-PD-1 and anti-PD-L1 antibodies, have demonstrated remarkable efficacy in suppressing malignancy by stimulating antitumor T-cell im-  \nmunity [8,11,12] . PD-1 and its ligand inhibit antitumor T-cell immunity in the following two ways: 1) PD-L1 downregulates MHC-I, which decreases antigen presentation in tumor cells and dampens CD8 + T-cell killing ability; 2) PD-1-expressing CD8 + T cells are contributes to T cell exhaustion [13–15] . Therefore, a PD-1-or PD-L1-mediated decrease in terminal effector T cells induces immune silencing. However, anti-PD-1 and anti-PD-L1 antibodies increase the level of MHC-I on the surface of tumor cells, which suppresses immune evasion in GC [16] . Therefore, MHC-I may be a  \npotential target fo","cbCaigtEeQWePsHQ","https://ap.wps.com/l/cbCaigtEeQWePsHQ","pdf",1887237,"English","# Introduction\n## Immune checkpoint blockade and MHC-I\n## PACSIN1 background and rationale\n# Materials and Methods\n## Specimen\n## Immunohistochemistry (IHC) assay","[{\"question\":\"What is the study’s main goal regarding PACSIN1 in gastric cancer?\",\"answer\":\"To investigate whether PACSIN1 can serve as a target for GC treatment by clarifying its role in tumor biology and antitumor immunity.\"},{\"question\":\"How does PACSIN1 deficiency affect autophagy and antigen presentation in GC cells?\",\"answer\":\"PACSIN1 deficiency inhibits autophagy but increases antigen presentation by disrupting lysosomal fusion and selective autophagy of MHC-I.\"},{\"question\":\"What are the in vivo effects of PACSIN1 knockout on tumor progression and immune infiltration?\",\"answer\":\"PACSIN1 knockout suppresses tumor growth and liver metastasis in vivo while increasing CD8+ T-cell infiltration.\"}]","PACSIN1 promotes immunosuppression in gastric cancer by degrading MHC-I | PDF",1790045027,25,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2767ab23c3960bd827842aa43279cbe6.webp",983,1269,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e32a8961c55c9b82d3d342d54b417a5b.webp",982,1268,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/be12067cf84a02c03d23af502f945d8f.webp",981,1266,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5c4ec6b105970d2819b64880f6adecfb.webp",980,1265]